Cite
HARVARD Citation
Eslami, G. et al. (2020). The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19. Journal of antimicrobial chemotherapy. pp. 3366-3372. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Eslami, G. et al. (2020). The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19. Journal of antimicrobial chemotherapy. pp. 3366-3372. [Online].